Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study - Nowicki - 2011 - International Journal of Clinical Practi
Links shared publicly online about this topic.
- 0total visits
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study - Nowicki - 2011 - International Journal of Clinical Practi
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study - Nowicki - 2011 - International Journal of Clinical Practice - Wiley Online Library
View full resource at onlinelibrary.wiley.com
Tags: Diabetes, Diabetes Type 2 Medication, Type 2 Diabetes, Kidney Health, Urinary System, Onglyza, Safety
Most Recently Shared on October 11, 2011 at 10:07 pm By:
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in… http://t.co/FVrFij7B viaIJCPRSS
Advertisement
